Cardiac Syndrome X: Update
Shilpa Agrawal1, Puja K Mehta2, C Noel Bairey Merz2
1David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA 90095, USA.
Insights
Cardiac Syndrome X (CSX) affects many women, causing chest discomfort and impacting quality of life. Research explores its causes, including microvascular dysfunction, and various treatments, though clear guidelines are missing.
Area of Science:
- Cardiology
- Women's Health
Background:
- Cardiac Syndrome X (CSX) presents as angina-like chest discomfort with exercise-induced ST depression, despite normal coronary arteries.
- This condition is common in women and associated with poor cardiovascular outcomes and reduced quality of life.
Purpose of the Study:
- To review the pathogenesis and treatment strategies for Cardiac Syndrome X.
- To highlight the need for comprehensive therapeutic guidelines for CSX management.
Main Methods:
- Literature review of studies on Cardiac Syndrome X.
- Analysis of implicated pathophysiological mechanisms including microvascular dysfunction and nociception.
- Summary of current pharmacological and non-pharmacological treatment options.
Main Results:
- CSX pathogenesis involves coronary microvascular dysfunction, endothelial dysfunction, and altered cardiac nociception.
- Effective treatments include lifestyle changes, medications (anti-anginal, anti-atherosclerotic, anti-ischemic), and non-pharmacological therapies.
- Individual treatment efficacies are documented, but a lack of consolidated guidelines exists.
Conclusions:
- Cardiac Syndrome X requires multifaceted management strategies.
- Further research is needed to establish evidence-based guidelines for optimal patient care.
Abstract:
Cardiac Syndrome X (CSX), characterized by angina-like chest discomfort, ST segment depression during exercise, and normal epicardial coronary arteries at angiography, is highly prevalent in women. CSX is not benign, and linked to adverse cardiovascular outcomes and a poor quality of life. Coronary microvascular and endothelial dysfunction and abnormal cardiac nociception have been implicated in the pathogenesis of CSX. Treatment includes life-style modification, anti-anginal, anti-atherosclerotic, and anti-ischemic medications. Non-pharmacological options include cognitive behavioral therapy, enhanced external counterpulsation, neurostimulation, and stellate ganglionectomy. Studies have shown the efficacy of individual treatments but guidelines outlining the best course of therapy are lacking.
More Related Videos
Related Concept Videos
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
Introduction Cardiac Emergencies
Coronary Artery Disease III: Clinical Manifestations
Acute Coronary Syndrome I: Introduction
Acute Coronary Syndrome V: Nursing Management
Acute Coronary Syndrome III: Diagnostic Studies


